Option Care Health, Inc. OPCH

Healthcare SIC 8082 - Services-Home Health Care Services NAICS Health Care and Social Assistance › Ambulatory Health Care Services › Home Health Care Services derived Nasdaq

Option Care Health, Inc. ("Option Care Health", "we", "us", "our", or the "Company") is the largest independent provider of home and alternate site infusion services through its national network of 196 locations in 43 states. Option Care Health draws on over 40 years of clinical care experience to offer patient-centered, cost-effective infusion therapy. Option Care Health's infusion services include the clinical management of infusion therapy, nursing support and care coordination. Option Care Health's multidisciplinary team of more than 5,000 clinicians, including pharmacists, pharmacy technicians, nurses and dietitians, are able to provide infusion service coverage for nearly all patients across the United States ("U.S.") needing treatment for complex and chronic medical conditions.

Last close 31.23 2026-10-26
Market cap $4.90B 2026-03-31 share count
52-week range 18.01 - 36.80

Valuation FY2025 figures against the last close

P/S0.9x
P/E24.6x
P/FCF22.6x
EV/EBITDA14.4x
Dividend yield—
Diluted EPS1.27

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $5.65B$5.00B$4.30B$3.87B$3.44B$3.03B$2.31B$1.94B$1.83B$935.6M
Cost of revenue $4.56B$3.99B$3.32B$2.56B$2.66B$2.35B$1.80B$1.52B$1.38B$673.5M
Gross profit $1.09B$1.01B$981.2M$866.9M$779.6M$682.3M$513.0M$422.2M$446.0M$262.1M
SG&A $682.5M$630.3M$607.4M$566.1M$525.7M$500.2M$459.6M$345.9M$338.5M$38.8M
Total operating expenses $750.0M$691.2M$666.6M$626.7M$588.8M$571.5M$513.3M$383.9M$418.7M$273.1M
Operating income $337.9M$321.8M$314.6M$240.2M$190.8M$110.8M-$319.0K$38.3M$27.3M-$11.0M
Interest expense $54.6M$49.0M$51.2M$53.8M$67.0M$107.8M$73.7M$45.8M$52.1M$37.6M
Pre-tax income $282.9M$283.6M$358.7M$205.8M$116.5M-$5.2M-$78.2M-$51.0M-$67.4M-$34.2M
Income tax $75.3M$71.8M$91.7M$55.2M$23.4M$2.8M$2.3M$2.7M$18.6M$2.0M
Net income $207.6M$211.8M$267.1M$150.6M$139.9M-$8.1M-$75.9M-$6.1M$3.9M-$42.8M
EPS, basic 1.281.231.490.830.78-0.04-0.49———
EPS, diluted 1.271.231.480.830.77-0.04-0.49-0.040.03-0.55
Shares, diluted (wtd. avg.) 163.4M172.8M180.4M182.1M181.2M181.0M156.3M———

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $232.6M$412.6M$343.8M$294.2M$119.4M$99.3M$67.1M$36.4M$53.1M$44.9M
Receivables $473.6M$409.7M$377.7M$377.5M$338.2M$328.3M$324.4M$310.2M$85.5M$109.1M
Inventory $471.1M$388.1M$274.0M$224.3M$183.1M$158.6M$115.9M$83.3M$38.0M$36.2M
Total current assets $1.26B$1.32B$1.09B$994.3M$710.3M$657.0M$558.7M$467.4M$186.6M$173.3M
Property, plant and equipment $139.2M$127.4M$120.6M$108.3M$111.5M$121.1M$133.2M$93.1M$27.0M$32.7M
Goodwill $1.61B$1.54B$1.54B$1.53B$1.48B$1.43B$1.43B$632.5M$627.4M$365.9M
Other intangibles $309.2M$301.0M$335.4M$364.1M$366.0M$351.1M$385.9M$219.7M$19.1M$31.0M
Total assets $3.46B$3.42B$3.22B$3.11B$2.79B$2.65B$2.59B$1.43B$603.1M$605.0M
Accounts payable $639.8M$610.8M$426.5M$378.8M$279.2M$282.9M$221.1M$187.9M$66.0M$64.4M
Short-term debt $6.8M$6.5M$6.0M$6.0M$6.0M$9.2M$9.2M$4.2M$1.7M$18.5M
Total current liabilities $829.3M$780.1M$618.3M$565.4M$459.7M$434.0M$330.0M$240.0M$105.1M$130.1M
Long-term debt $1.15B$1.10B$1.06B$1.06B$1.06B$1.12B$1.28B$535.2M$502.9M$467.7M
Total liabilities $2.13B$2.02B$1.80B$1.73B$1.62B$1.63B$1.68B$825.4M$605.8M$566.6M
Retained earnings $876.9M$669.3M$457.5M$190.4M$39.9M-$100.0M-$92.0M-$16.0M-$709.5M-$645.3M
Total equity $1.33B$1.40B$1.42B$1.39B$1.18B$1.02B$906.8M$602.8M$606.1M$600.8M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $258.4M$323.4M$371.3M$267.5M$208.6M$127.4M$39.5M$24.4M$37.9M-$42.5M
Depreciation and amortisation $67.5M$60.9M$59.2M$60.6M$63.1M$71.3M$53.7M$38.1M$34.7M$22.0M
Stock-based compensation $40.0M$36.1M$30.5M$16.8M$9.6M$2.9M$4.2M$2.1M$1.5M$1.8M
Capital expenditure $41.3M$35.6M$41.9M$35.4M$25.6M$26.9M$28.3M$26.3M$25.0M—
Investing cash flow -$161.1M-$36.5M-$56.5M-$108.1M-$111.5M-$26.3M-$727.8M-$37.0M-$24.5M-$73.2M
Financing cash flow -$277.3M-$218.2M-$265.1M$15.3M-$76.9M-$68.8M$719.0M-$4.2M-$5.2M$109.7M
Buybacks $310.0M$252.7M$250.3M$75.0M$0—————

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001140361-26-013825.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -2B 0 2B 4B 6B Revenue, FY2016: 935.6M Gross profit, FY2016: 262.1M Net income, FY2016: -42.8M Revenue, FY2017: 1.8B Gross profit, FY2017: 446M Net income, FY2017: 3.9M Revenue, FY2018: 1.9B Gross profit, FY2018: 422.2M Net income, FY2018: -6.1M Revenue, FY2019: 2.3B Gross profit, FY2019: 513M Net income, FY2019: -75.9M Revenue, FY2020: 3B Gross profit, FY2020: 682.3M Net income, FY2020: -8.1M Revenue, FY2021: 3.4B Gross profit, FY2021: 779.6M Net income, FY2021: 139.9M Revenue, FY2022: 3.9B Gross profit, FY2022: 866.9M Net income, FY2022: 150.6M Revenue, FY2023: 4.3B Gross profit, FY2023: 981.2M Net income, FY2023: 267.1M Revenue, FY2024: 5B Gross profit, FY2024: 1B Net income, FY2024: 211.8M Revenue, FY2025: 5.6B Gross profit, FY2025: 1.1B Net income, FY2025: 207.6M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $935.6M $1.83B $1.94B $2.31B $3.03B $3.44B $3.87B $4.30B $5.00B $5.65B
Gross profit $262.1M $446.0M $422.2M $513.0M $682.3M $779.6M $866.9M $981.2M $1.01B $1.09B
Net income -$42.8M $3.9M -$6.1M -$75.9M -$8.1M $139.9M $150.6M $267.1M $211.8M $207.6M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8082

TickerCompanyMarket capP/ERevenue growth
BTSG BrightSpring Health Services, Inc. $11.65B 67.7x 28.2%
CHE CHEMED CORP $6.70B 28.0x 4.1%
AVAH Aveanna Healthcare Holdings, Inc. $2.88B 12.6x 20.2%
ADUS Addus HomeCare Corp $2.26B 23.2x 23.2%
AHCO AdaptHealth Corp. $808.5M — -0.5%